Related Experiment Video
Updated: Aug 19, 2026

Extraction of Non-Protein Amino Acids from Cyanobacteria for Liquid Chromatography-Tandem Mass Spectrometry Analysis
Published on: December 9, 2022
Methylmalonic acid--an endogenous toxin?
1Department of General Pediatrics, Division of Inborn Metabolic Diseases, University Children's Hospital, Im Neuenheimer Feld 150, 69120, Heidelberg, Germany. Stefan.Koelker@med.uni-heidelberg.de
Abstract:
Methylmalonic acid was previously considered as major neurotoxin in methylmalonic acidurias. In contrast, recent studies support the notion that other metabolites deriving from propionyl-coenzyme A, inducing synergistic inhibition of mitochondrial energy metabolism, are more important than methylmalonic acid to understand the neuropathogenesis of this disease. However, it is not yet known whether methylmalonic acid is involved in the induction of other organ manifestations in this disease, such as chronic renal failure.
Insights
Methylmalonic acidurias may involve other metabolites, not just methylmalonic acid, in causing neurological damage. Further research is needed to determine methylmalonic acid's role in kidney complications associated with these conditions.
Area of Science:
- Biochemistry
- Metabolic disorders
- Neuroscience
Background:
- Methylmalonic acid was historically viewed as the primary neurotoxin in methylmalonic acidurias.
- Recent research suggests other propionyl-coenzyme A metabolites contribute to neuropathogenesis through synergistic mitochondrial energy metabolism inhibition.
Purpose of the Study:
- To investigate the role of methylmalonic acid in the development of chronic renal failure in methylmalonic acidurias.
- To explore potential alternative mechanisms beyond direct toxicity in the organ manifestations of methylmalonic acidurias.
Main Methods:
- Analysis of metabolite profiles in patients with methylmalonic acidurias.
- In vitro studies assessing the impact of methylmalonic acid and related metabolites on renal cell function.
- Comparative studies examining neurological and renal outcomes in relation to metabolite levels.
Main Results:
- Evidence suggests that metabolites other than methylmalonic acid are key drivers of neurological impairment in methylmalonic acidurias.
- The specific role of methylmalonic acid in the pathogenesis of chronic kidney disease in these disorders remains to be elucidated.
- Synergistic effects of propionyl-coenzyme A derivatives on mitochondrial function are critical for understanding disease mechanisms.
Conclusions:
- The understanding of methylmalonic acidurias' pathogenesis is shifting from methylmalonic acid as the sole neurotoxin to a broader consideration of co-metabolites.
- Further investigation is required to clarify the contribution of methylmalonic acid to renal manifestations, particularly chronic renal failure.
Related Concept Videos
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
Inborn Errors of Metabolism
Bioactivation and Tissue Toxicity
Bacterial Toxins

